The Asian Pacific Association for the Study of the Liver [APASL]

Visit our Mobile App!


Let's stay Connected via APASL 2021 BANGKOK Mobile App!

Download it from App Store or Google Play Store or scan this QR Code.





Empathy Letter


Dear colleagues,

We are writing on behalf of the APASL Leadership. The past several weeks have been a challenge not only to our subspecialty but for all allied subspecialties and personnel as we continue to afford a broader effort to help strengthen the global response to the novel coronavirus outbreak. We know that government interagency in each country and WHO have robust arrangements to monitor and managing this situation closely. We believe strongly that the region will emerge against the disease successfully. Keep safe and hope to see you soon.
Thank you.
------------------------------------
APASL Steering Committee
Dr. Shiv K Sarin, Dr. Rino Gani, Dr. Diana A. Payawal,
Dr. Tawesak Tanwandee, Dr. Lai Wei,
Dr. Darrell Crawford, Dr. A. Kadir Dokmeci, Dr. Jinlin Hou,
Dr. Ji-Dong Jia, Dr. Jia-Horng Kao, Dr. George Lau,
Dr. Laurentius A. Lesmana, Dr. Masao Omata, Dr. Teerha Piratvisuth,
Dr. Barjesh C. Sharma, Dr. Jose Sollano, Dr. Dong Jin Suh, Dr. Osamu Yokosuka

Updated Topics


Information on APASL 2020 in Bangkok



Date: February 3-6, 2021
City: Bangkok, Thailand
President: Dr. Tawesak Tanwandee
View APASL 2021 Website


Welcome Message

"Dear friends and colleagues,

On behalf of Thai Association for Study of the Liver, it is our great pleasure to invite you to participate in the 30th Asian Pacific for The Study of Liver (APASL) 2021, to be held on 3 to 6 February 2021 in Bangkok, Thailand.

Since 1978, APASL has been actively striving towards the advancements of Hepatology studies. Our main objectives are to promote the latest scientific advancement and education of hepatology science, exchange of information and the development of consensus, encourage the practice of medicine in liver diseases and also coordinate scientific studies between various scientists and clinicians throughout the region.

APASL 2021 will continue to reinforce these objectives, bringing together experts and veterans in the hepatology field from all around Asia Pacific, as well as in the world. The congress will feature a finely cultivated scientific programme, delivered by the best speakers, together with many interactive sessions and social programmes, promising the best platform for our participants to exchange knowledge and growth. Additionally, abstract competition and workshops will enhance the learning experience. APASL 2021 will also be an excellent platform for industry players and trade companies to showcase the latest products and solutions.

The congress will be held in Bangkok, Thailand - the leading metropolitan area in Asia. You will enjoy a unique and inspiring experience with Thailand's distinctive culture and legendary hospitality.

We look forward to seeing you in Bangkok!"

- Dr Tawesak Tanwandee, APASL President (with effect from March 2020)

APASL STC 2020 Osaka


Abstract Submission is now available!

Deadline of abstract submission: May 31, 2020

(Submit from here!)


Please check out the trailer of APASL STC 2020 Osaka!

Date: September 24-26, 2020
City: Osaka, Japan
President: Dr. Norifumi Kawada

View APASL STC 2020 Osaka Website


"Liver Diseases in the Asia Pacific Region"


Dear APASL Members,
Please check "Liver Diseases in the Asia Pacific Region" published in The Lancet Gastroenterology and Hepatology on December 15. You will find it useful. Click on the image and access to the paper. If you like it, please share with your colleagues.


Hep-I OFFICIAL Twitter page has opened!


Hepatology International official Twitter page has opened!

You can check it out from the link below. Please follow us!

https://twitter.com/hepinternation1?s=20


You can also check out Hepatology International from here!



APASL STC 2020 Yangon


Pamphlet of APASL STC 2020 is now available!
This STC will be the 36th Single Topic Conference of APASL and the 8th APASL HCV Conference.
The topic is "Elimination of HCV"

Click on the image and check the PDF to see the information of this meeting!


DATE AND LOCATION:
DATE: December 5-6, 2020
LOCATION: Novotel Yangon Max Hotel, Yangon, Myammar
CONTACTS:
OFFICIAL WEBSITE: https://www.apaslstc2020yangon.com
E-MAIL: secretariat@apaslstc2020yangon.com

Call to Action for HCV Elimination Signed.


On November 10 at AASLD meeting, "Call to Action for Liver Association to Advance Progress Towards Viral Hepatitis Elimination: A Focus on Simplified Approaches to HCV Testing and Cure" was signed between AASLD, EASL, APASL, ALEH and acknowledgement of collaboration with CHAI, Clinton Health Access Initiative. As the number of patients of HCV is increasing all over the world, we have decided to work together to eliminate the patients until 2030. We are focusing on 4 specific themes that address the roles that liver associations and their constituents should play in eliminating HCV:

[Simplification] of diagnostic and treatment algorithms towards the goal of a one-stop "test and cure" for HCV
[Integration] of HCV treatment with primary care and other disease programs (e.g. TB, HIV) and outreach settings(harm reduction)
[Decentralization] of HCV services from large urban referral hospitals to local level care
[Task-sharing] of HCV care for Uncomplicated cases with primary care clinicians, medical officers, advanced practice clinicians, nurses, pharmacists and trained community health workers where available.

We continue working hard on eliminating HCV patients.



APASL Official YouTube Channel has been launched!


The APASL official YouTube Channel has been launched! You can watch the highlights of APASL scientific programs. Click on the image below and check it out!



Hep-I Impact Factor jumped up to 5.49!


Dear Colleagues,
Hepatology International, in association with Springer Nature, is extremely delighted to share with you the 2018 Impact Factor of HEPI which has touched a new high of 5.49 from 4.11 in 2017. More so, we have jumped into the TOP 20 Journals of Gastroenterology and Hepatology and are placed at position 17.
A significant feat for our journal indeed!
It never goes without saying that this would not have been possible without your support.
We look forward to grow together as a team and steer our journal, Hepatology International, towards a more purposeful space in the field of hepatology. With best regards,

Prof Masao Omata / Prof. Shiv Sarin

SharedIt services: A boon for Authors/Researchers

SharedIt is part of Springer Nature initiative that allows authors to share their research to wider communities by enabling over 200 key media outlets and blogs to link to free-to-read versions of research articles. This media list has been significantly expanded to coincide with the expansion of the initiative across the Springer Nature portfolio. Many on this media list are aimed at the public, including BBC, The Economist, WIRED, The New York Times, as well as leading science bloggers.

Upon publication, corresponding authors are emailed a shareable link to view-only versions of their peer-reviewed research papers. All corresponding authors are sent this link, even those with papers published in open access journals. A stable, shortened URL is made available for published authors to share the full-text access to their paper by using the link http://rdcu.be/p2UW

Enhanced PDF: The link takes the author to a read-only enhanced PDF format of their published paper.

For open-access articles, all readers will be able to download, print and save an enhanced PDF, or to view the full-text HTML version.

For subscription articles, only subscribers will be able to download, print and save an enhanced PDF, or to view the full-text HTML version.

Authors can request shareable links of other research articles that they have authored with most Springer Nature journals by entering the article's DOI into our author portal

Springer Nature has a sample social media plan to help authors promote their research via Facebook and Twitter. The four-week campaign utilizes the SharedItlink to gain visibility through concentrated daily marketing, using both direct and indirect (post comments) methods.

For more Information please visit the SharedIt page on Springernature.com.



Future Meetings

APASL STC 2020 on Portal Hypertension in China
Date: June 5-7, 2020
City: Guangzhou, China
President: Dr. Xiaolong Qi
Website: www.apaslstc.com


APASL STC 2020 on Molecular Biology in Japan
Date: September 24-26, 2020
City: Osaka, Japan
President: Dr. Norifumi Kawada
Website: http://www.apaslstc-osaka2020.org/


APASL STC 2020 on Alcohol Liver in India
Date: October 2-4, 2020
City: Gangtok, India
President: Dr. M.R Kotwal
Website: to be announced.

APASL STC 2020 on Elimination of Hepatitis C in Myanmar
Date: December 5-6, 2020
City: Yangon, Myanmar
President: Dr. Khin Maung Win
Website: http://www.apaslstc2020yangon.com/
Hosting Organization: GI and Liver Foundation (GLF) (Myanmar)
Conference President: Prof. Khin Maung Win
Organizing Chairperson: Prof. Than Than Swe
Organizing Vice-Chairs: Prof. Kyaw Soe Tun and Prof. Win Naing
Academic Committee Chairperson: Prof. Khin Maung Win
Conference Secretariat: Yangon GI and Liver Centre (YGLC)
yangongiandlivercentre@gmail.com
secretariat@apaslstc2020yangon.com


APASL Oncology 2020

Date: December 17-19, 2020
City: Tokyo, Japan
President: Dr. Mitsuhiko Moriyama
Website: http://www.apasl-oncology2020.org/


APASL 2021 Annual Meeting in Bangkok

Date: February 3-6, 2021
City: Bangkok, Thailand
President: Dr. Tawesak Tanwandee
Website: https://www.apasl2021bangkok.org/

APASL STC 2021 on Critical Care in Hepatology: ACLF
Date: September 17-19, 2021
City: Wuhan, China
President: Dr. Qin Ning
Website: http://www.apaslstc2021wh.com

APASL STC 2021 on NAFLD/NASH: Non-Infection Epidemic in XXI
Date: October 8-10, 2021
City: Yerevan, Armenia
President: Dr. Hasmik Ghazinian
Website: to be announced.


APASL STC 2021 on Advances in the Prevention and Management of Liver Cirrhosis and Its Complication
Date: June 11-12, 2021
City: Manila, Philippines
President: Dr. Ian Homer Y. Cua
Website: to be announced.

APASL 2022 Annual Meeting in Korea
Date: March 30-April 3, 2022
City: COEX, Seoul, Korea
President: Dr. Jin Mo Yang
Website: to be announced.

Related Meetings

Baveno VII-Consensus Workshop Personalized Care in Portal Hypertension
Date: June 18-21, 2020
City: Baveno, Italy
Website: http://www.baveno7.com/


Global Hepatitis Summit 2020
Date: June 18-21, 2020
City: Taipei, Taiwan
Website: https://ghs2020taipei.com/


IDEN 2020
Date: September 24-27, 2020
City: BEXCO, Busan, Korea
Website: https://www.iden.or.kr/


APDW 2020
Date: December 7-10, 2020
City: Kuala Lumpur, Malaysia
Website: https://www.apdw2020.org/



Hep-I Impact Factor jumped up to 5.49!

Dear Colleagues,

Please be informed the Impact Factor of our Official Journal “Hepatology International” is now 5.49!

Sincerely,
Masao Omata MD
Shiv K Sarin MD
Chief in Editor of Hepatology International

APASL Guidelines

The Guideline written by Dr. T Kanda has been published!

APASL Guidelines for HCC -”Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update” (Hepatol Int 2017; 11: 317-370)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for HBV -"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update" (Hepatol Int 2016; 10:1–98)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for HCV -”APASL consensus statements and recommendation for hepatitis C prevention, epidemiology, and laboratory testing” (Hepatol Int 2016 10:681–701)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for HCV -”APASL consensus statements and recommendation on treatment of hepatitis C” (Hepatol Int 2016 10:702–726)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for Acute-on-chronic Liver Failure -”Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014” (Hepatol Int 2014; 8: 453-471)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for Fibrosis -”Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)” (Hepatol Int 2009; 3: 323-333)

*This APASL Guideline can be downloaded by clicking below.

APASL consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis a 2016 update (Hepatol Int 2017 11:1–30)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for IPH -”Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment” (Hepatol Int 2007; 1: 398-413)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for Variceal Bleeding -”Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver” (Hepatol Int 2008; 2: 429-439)

*This APASL Guideline can be downloaded by clicking below.


APASL Fellowship 2020

The objective of the fellowship is to foster career development by encouraging the beneficial experience of working in a different clinical or research environment in another country in the Asia-Pacific region. These fellowships provide for advanced training in health and medical research in any country in the Asia-Pacific region and enable fellows to work in a clinical environment or on a research project with nominated advisers. We appreciate your generous contributions and support for these APASL fellowships and look forward to a number of high-quality applications for a 2020 fellowship.

An application form can be downloaded by clicking here: Click here! Please fill in and send to the APASL secretariat (apasl_secretariat@apasl.info). We are looking forward to receiving your application. There are no restrictions based on nationality. The sponsoring institution with the academic environment to provide adequate support for the proposed project might be suggested by APASL. Application will be reviewed by APASL Committee members. The decisions of the Committee are final and not subject to appeal.